Role of nitric oxide in cancer biology

References

• Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacological Reviews 1991; 43: 109–141
   PubMed Web of Science ®Google Scholar
• Stuehr D.J., Marletta M.A. Mammalian nitrite biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceedings of the National Academy of Science of the United States of America 1985; 82: 7738–7742
   PubMed Web of Science ®Google Scholar
• Koshland D.E., Jr. The molecule of the year. Science 1992; 258: 1861–1861
   PubMed Web of Science ®Google Scholar
• Henry Y., Lepoivre M., Drapier J.C., Ducrocq C., Boucher J.L., Guissani A. ERP characterization of molecular targets of NO in mammalian cells and organelles. FASEB Journal 1993; 7: 1124–1134
   PubMed Web of Science ®Google Scholar
• Stamler J.S., Single D.J., Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992; 258: 1898–1902
   PubMed Web of Science ®Google Scholar
• Fukuto J.M. Chemistry of nitric oxide: Biologically relevant aspects. Nitric oxide — biochemistry, molecular biology and therapeutic implications. Advances in Pharmacology, L. Ignarro, F. Murad. Academic Press, USA 1995; 1–15, In
   Google Scholar
• Ignarro L.J. Heme-dependent activation of cytosolic guanylate cyclase by nitric oxide: A widespread signal transduction mechanism. Biochemical Society Transactions 1992; 20: 465–469
   PubMed Web of Science ®Google Scholar
• Ignarro L.J. Heme-dependent activation of soluble guany-late cyclase by nitric oxide: Regulation of enzyme activity by porphyrins and metallophorphyrins. Seminars in Hematology 1989; 26: 63–76
   PubMedGoogle Scholar
• Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Archives of Biochemistry and Biophysics 1991; 288: 481–487
   PubMed Web of Science ®Google Scholar
• Wink D.A., Vodovotz Y., Laval J., Laval F., Dewhirst M.W., Mitchell J.B. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19: 711–721
   PubMed Web of Science ®Google Scholar
• Wink D.A., Cook J.A., Kim S., Vodovotz Y., Pacelli R., Krishna M.C., Russo A., Mitchell J.B., Jourd'heuil D., Miles A.M., Grisham M.B. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide derived reactive intermediates. Journal of Biological Chemistry 1997; 272: 11147–11512
   PubMed Web of Science ®Google Scholar
• Correa P., Cuello C., Fajardo L.F., Haenszel W., Bolanos O., de Ramirez B. Diet and gastric cancer: Nutrition survey in a high-risk area. Journal of the National Cancer Institute 1983; 70: 673–678
   PubMed Web of Science ®Google Scholar
• Marquardt H., Rufino F., Weisburger J.H. Mutagenic activity of nitrite-treated foods: Human stomach cancer may be related to dietary factors. Science 1977; 196: 1000–1001
   PubMed Web of Science ®Google Scholar
• Taylor H.W., Lijinski W. Tumor induction in rats by feeding heptamethyleneimine and nitrite in water. Cancer Research 1975; 35: 812–815
   PubMed Web of Science ®Google Scholar
• Lintas C.L., Clark A., Fox J., Tannenbaum S.R., Newberne P.M. In vivo stability of nitrite and nitrosamine formation in the dog stomach: Effect of nitrite and amine concentration and of ascorbic acid. Carcinogenesis 1982; 3: 161–165
   PubMed Web of Science ®Google Scholar
• Weisburger J.H., Marquardt H., Hirota N., Mori H., Williams G.M. Induction of cancer of the glandular stomach in rats by an extract of nitrite-treated fish. Journal of the National Cancer Institute 1980; 64: 163–167
   PubMed Web of Science ®Google Scholar
• Mirvish S.S., Salmasi S., Cohen S.M., Patil K., Mahboubi E. Liver and forestomach tumors and other forestomach lesions in rats treated with morpholine and sodium nitrite, with and without sodium ascorbate. Journal of the National Cancer Institute 1983; 71: 81–85
   PubMed Web of Science ®Google Scholar
• Wink D.A., Hanbauer I., Grisham M.B., Laval F., Nims R.W., Laval J., Cook J.C., Pacelli R., Liebmann J., Krishna M.C., Ford M.C., Mitchell J.B. The chemical biology of NO. Insights into regulation, protective and toxic mechanisms of nitric oxide. Current Topics in Cellular Regulation 1996; 34: 159–187
   PubMedGoogle Scholar
• Marletta M.A. Mammalian synthesis of nitrite, nitrate, nitric oxide, and N-nitrosating agents. Chemical Research in Toxicology 1988; 1: 249–257
   PubMed Web of Science ®Google Scholar
• Miles A.M., Gibson M., Krishna M., Cook J.C., Pacelli R., Wink D.A., Grisham M.B. Effects of superoxide on nitric oxide-dependent N-nitrosation reactions. Free Radical Research 1995; 233: 379–390
   Google Scholar
• Liu R.H., Hotchkiss J.H. Potential genotoxicity of chronically elevated nitric oxide: A review. Mutation Research 1995; 339: 73–89
   PubMed Web of Science ®Google Scholar
• Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutation Research 1994; 305: 253–264
   PubMed Web of Science ®Google Scholar
• Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Keefer L.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 1991; 254: 1001–1003
   PubMed Web of Science ®Google Scholar
• Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences of the United States of America 1992; 89: 3030–3034
   PubMed Web of Science ®Google Scholar
• Merchant K., Chen H., Gonzales T.C., Keefer L.K., Shaw B.R. Deamination of single-stranded DNA cytosine residues in aerobic nitric oxide solution at micromolar total NO exposures. Chemical Research in Toxicology 1996; 9: 891–896
   PubMedGoogle Scholar
• DeRojas-Walker T., Tamir S., Ji H., Wishnok J.S., Tannenbaum S.R. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chemical Research in Toxicology 1995; 8: 473–477
   PubMed Web of Science ®Google Scholar
• Salgo M.G., Stone K., Squadrito G.L., Battista J.R., Pryor W.A. Peroxynitrite causes DNA nicks in plasmid pBR322. Biochemical and Biophysical Research Communications 1995; 210: 1025–1030
   PubMed Web of Science ®Google Scholar
• Ling-Ling C., Nakamura T., Nakatsu Y., Sakumi K., Hayakawa H. Specific amino acid sequences required for O6-methylguanine-DNA-methyltransferase activity: Analysis of three residues at or near the methyl acceptor site. Carcinogenesis 1992; 13: 837–843
   PubMedGoogle Scholar
• Zak P., Kliebl K., Laval F. Repair of O6-methylguanine and O4-methylthymine by human O6-methylguanine-DNA-methyltransferase. Journal of Biological Chemistry 1994; 269: 730–733
   PubMedGoogle Scholar
• Wink D.A., Nims R.W., Darbyshire J.F., Cristodoulou D., Hanbauer I., Cox G.W., Laval F., Laval J., Cook J.A., Krishna M.C., DeGraff W., Mitchell J.B. Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chemical Research in Toxicology 1994; 7: 519–525
   PubMed Web of Science ®Google Scholar
• Rhodes D., Klug A. Zinc fingers. Scientific American 1993; 268: 56–65
   PubMedGoogle Scholar
• Wink D.A., Laval J. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 1994; 15: 2125–2129
   PubMed Web of Science ®Google Scholar
• Messmer U.K., Ankarcrona M., Nicotera P., Brune B. P53 expression in nitric oxide-induced apoptosis. FEBS Letters 1994; 355: 23–26
   PubMed Web of Science ®Google Scholar
• Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. British Journal of Cancer 1995; 72: 41–44
   PubMed Web of Science ®Google Scholar
• Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Research 1994; 54: 1352–1354
   PubMed Web of Science ®Google Scholar
• Cobbs C.S., Brenman J.E., Aldape K.D., Bredt D.S., Israel M.A. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Research 1995; 55: 727–730
   PubMed Web of Science ®Google Scholar
• Radomski W., Jenkins D.C., Holmes L., Moncada S. Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets. Cancer Research 1991; 51: 6073–6078
   PubMed Web of Science ®Google Scholar
• Prazma J., Petrusz P., Mims W., Ball S.S., Weissler M.C. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngology and Head and Neck Surgery 1995; 13: 541–549
   Google Scholar
• Folkman J. Angiogenesis and angiogenesis inhibition: An overview. EXS 1997; 79: 1–8
   PubMedGoogle Scholar
• Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. New England Journal of Medicine 1991; 324: 1–8
   PubMed Web of Science ®Google Scholar
• Ambs S., Bennett W.P., Merriam W.G., Ogunfusika M.O., Oser S.M., Harrington A.M., Shields P.G., Felley-Bosco E., Hussain S.P., Harris C.C. Relationship between p53 mutations and inducible nitric oxide synthase expression in human colorectal cancer. Journal of the National Cancer Institute 1999; 91: 86–88
   PubMed Web of Science ®Google Scholar
• Moochhala S.M., Chhatwall V.J.S., Chan S.T.F., Ngoi S.S., Chia Y.W., Rauff A. Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996; 17: 1171–1174
   PubMed Web of Science ®Google Scholar
• Sutherland R.M., Rasey J.S., Hill R.P. Tumor biology. American Journal of Clinical Oncology 1988; 11: 253–274
   PubMedGoogle Scholar
• Pipili-Synetos E., Papageorgiou A., Sakkoula E., Sotiropoulou G., Fotsis G., Karakiulakis G., Maragoudakis M. Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. British Journal of Pharmacology 1995; 116: 1829–1834
   PubMed Web of Science ®Google Scholar
• De Man J.G., Pelckmans P.A., Boeckxstaens G.E., Bult H., Oosterbosch L., Hatjikondi O., Ravazoula P., Kardamakis D., Dimopoulos J., Papaioannou S. In vivo experimental evidence that the nitric oxide pathway is involved in the X-ray-induced antiangiogenicity. British Journal of Cancer 1996; 74: 1916–1923
   PubMedGoogle Scholar
• Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., Geppetti P., Ledda F. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. Journal of Clinical Investigation 1994; 94: 2036–2044
   PubMed Web of Science ®Google Scholar
• Jenkins D.C., Charles I.G., Thomsen L.L., Moss D.W., Holmes L.S., Baylis S.A., Rhodes P., Westmore K., Emson P.C., Moncada S. Roles of nitric oxide in tumor growth. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 4392–4396
   PubMed Web of Science ®Google Scholar
• Lepoivre M., Chenais B., Yapo A., Lemaire G., Thelander L., Tenu J.P. Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. Journal of Biological Chemistry 1990; 265: 14143–14149
   PubMed Web of Science ®Google Scholar
• Lepoivre M., Fieschi F., Coves J., Thelander L., Fontecave M. Inactivation of ribonucleotide reductase by nitric oxide. Biochemical and Biophysical Research Communications 1991; 179: 442–448
   PubMed Web of Science ®Google Scholar
• Lepoivre M., Flaman J.M., Henry Y. Early loss of the tyrosyl radical in ribonucleotide reductase of adenocarcinoma cells producing nitric oxide. Journal of Biological Chemistry 1992; 267: 22994–23000
   PubMed Web of Science ®Google Scholar
• Lancaster J.R., Hibbs J.B. EPR demonstration of ironnitrosyl complex formation by cytotoxic activated macrophages. Proceedings of the National Academy of Sciences of the United States of America 1990; 87: 1223–1227
   PubMed Web of Science ®Google Scholar
• Drapiers J.C., Hirling H., Wietzerbin J., Kaildy P., Kuhn L.C. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO Journal 1993; 12: 3643–3649
   PubMedGoogle Scholar
• Weiss G., Goossen B., Doppler W., Pantopoulos K., Werner-Felmayer G., Hentze M.W. Translational regulation via iron-responsive elements by the nitric oxide/NO synthase pathway. EMBO Journal 1993; 12: 3651–3657
   PubMed Web of Science ®Google Scholar
• Bouton C., Raveau M., Drapier J.C. Modulation of iron regulatory protein function. Further roles of nitrogen and oxygen-derived reactive species. Journal of Biological Chemistry 1996; 271: 2300–2306
   PubMed Web of Science ®Google Scholar
• Graziewicz M., Wink D.A., Laval F. Nitric oxide inhibits DNA ligase activity. Potential mechanism for NO mediated DNA damage. Carcinogenesis 1996; 17: 2501–2505
   PubMed Web of Science ®Google Scholar
• Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrate oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. Journal of Biological Chemistry 1991; 266: 4244–4250
   PubMed Web of Science ®Google Scholar
• Spencer J.P., Wong J., Jenner A., Aruoma O.I., Cross C.E., Halliwell B. Base modification and strand breakage in isolated calf thymus DNA and in DNA from human skin epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Chemical Research in Toxicology 1996; 9: 1152–1158
   PubMed Web of Science ®Google Scholar
• Ohshima H., Yoshie Y., Auriol S., Gilibert I. Anti-oxidant and pro-oxidant actions of flavonoids: Effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion. Free radical Biology and Medicine 1998; 25: 1057–1065
   PubMed Web of Science ®Google Scholar
• Forrester K., Ambs S., Lupold S.E., Kapust R.B., Spillare E.A., Weinberg W.C., Felley-Bosco E., Wang X.W., Geller D.A., Tzeng E., Billiar T.R., Harris C.C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 2442–2447
   PubMed Web of Science ®Google Scholar
• Baker S.J., Markowitz S., Fearon E.R., Willson J.K.V., Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249: 912–915
   PubMed Web of Science ®Google Scholar
• Kastan M.B., Onykewere O., Sidransky D., Vogelstein B., Craig R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Research 1991; 51: 6304–6311
   PubMed Web of Science ®Google Scholar
• Tsuji S., Tsujii M., Sun W.H., Gunawan E.S., Murata H., Kawano S., Hori M. Helicobacter pylori and gastric carcinogenesis. Journal of Clinical Gastroenterology 1997; 25: S186–S197
   PubMedGoogle Scholar
• Dameron K.M., Volpert O.V., Tainsky M.A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265: 1582–1584
   PubMed Web of Science ®Google Scholar
• Graeber T.G., Osmanian C., Jacks T., Housman D.E., Koch C.J., Lowe S.W., Giaccia A.J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.) 1996; 379: 88–91
   PubMed Web of Science ®Google Scholar
• Ambs S., Merriam W.G., Ogunfusika M.O., Bennett W.P., Ishibe N., Hussain S.P., Tzeng E.E., Geller D.A., Billiar T.R., Harris C.C. P53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nature Medicine 1998; 4: 1371–1376
   PubMed Web of Science ®Google Scholar
• Melillo, G., et al. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. Journal of Experimental Medicine 1995; 182: 1683–1693
   PubMed Web of Science ®Google Scholar
• Montrucchio G., Lupia E., de Martino A., Battaglia E., Arese M., Tizzani A.S., Bussolino F., Camussi G. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-α. American Journal of Pathology 1997; 151: 557–563
   PubMedGoogle Scholar
• Wu N.Z., Klitzman B., Dodge R., Dewhirst M.W. Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Research 1992; 52: 4265–4268
   PubMed Web of Science ®Google Scholar
• Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 9114–9119
   PubMed Web of Science ®Google Scholar
• Nakano S., Matsukado K., Black K.L. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Research 1996; 56: 4027–4031
   PubMed Web of Science ®Google Scholar
• Orucevic A., Lala P.K. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice. Cancer Immunology, Immunotherapy 1996; 42: 38–46
   PubMedGoogle Scholar
• Parkins C.S., Dennis M.F., Stratford M.R., Hill S.A., Chaplin D.J. Ischemia reperfusion injury in tumors: The role of oxygen radicals and nitric oxide. Cancer Research 1995; 55: 6026–6029
   PubMedGoogle Scholar
• Lejeune P., Lagade C.P., Onier N., Pinard D., Ohshima H., Jeannin J.F. Nitric oxide involvement in tumor-induced immunosuppression. Journal of Immunology 1994; 152: 5077–5083
   PubMed Web of Science ®Google Scholar
• Mills C.D. Molecular basis of ‘supressor’ macrophages. Arginine metabolism via the nitric oxide synthetase pathway. Journal of Immunology 1991; 146: 2719–2723
   PubMed Web of Science ®Google Scholar
• Hubbard N.E., Erickson K.L. Role of 5-lipoxygenase metabolites in the activation of peritoneal macrophages for tumoricidal function. Cellular Immunology 1995; 160: 115–122
   PubMedGoogle Scholar
• Salvemini D., Misko T.P., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 7420–7444
   Google Scholar
• Gardner T.E., Naama H., Daly J.M. Peritoneal and splenic macrophage functions in the tumor-bearing host. Journal of Surgical Research 1995; 59: 305–310
   PubMed Web of Science ®Google Scholar
• Maeda H., Noguchi Y., Sato K., Akaike T. Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Japanese Journal of Cancer Research 1994; 85: 331–334
   PubMedGoogle Scholar
• Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995; 83: 493–501
   PubMed Web of Science ®Google Scholar
• Sawaoka H., Tsuji S., Tsujii M., Gunawan E.S., Nakama A., Takei Y., Nagano K., Matsui H., Kawano S., Hori M. Expression of the cyclooxygenase-2 gene in gastric epithelium. Clinical gastroenterology 1997; 25: S105–S110
   PubMedGoogle Scholar
• Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. British Journal of Cancer 1995; 72: 41–44
   PubMed Web of Science ®Google Scholar
• Ellie E., Loiseau H., Lafond F., Arsaut J., Demotes-Mainard J. Differential expression of inducible nitric oxide synthase mRNA in human brain tumors. Neuroreport 1995; 7: 294–296
   PubMedGoogle Scholar
• Cascinu S., Graziano F., Del Ferro E., Staccioli M.P., Ligi M., Carnevali A., Muretto P., Catalano G. Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma. Cancer 1998; 83: 1917–1922
   PubMed Web of Science ®Google Scholar
• Joypaul, B.V., Hopwood, D., Newman, E.L., Qureshi, S., Grant, A., Ogston, S.A., et al. The prognostic significance of the accumulation of p53 tumor suppressor gene protein in gastric adenocarcinoma. British Journal of Cancer 1994; 69: 943–946
   PubMed Web of Science ®Google Scholar
• Gabbert H.E., Muller W., Schneiders A., Meier S., Hommel G. The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma. Cancer 1995; 76: 720–726
   PubMed Web of Science ®Google Scholar
• Victorzon M., Nordling S., Haglund C., Lundin J., Roberts P.J. Expression of p53 protein as a prognostic factor in patients with gastric cancer. European Journal of Cancer 1996; 32A: 215–220
   PubMed Web of Science ®Google Scholar